Caribou Biosciences (CRBU) Return on Capital Employed Growth (1y) (2022 - 2026)
Caribou Biosciences (CRBU) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 2,400.00 |
| 10 | Caribou Biosciences | 154.82 Mn | 37.19 Mn | - | -3,071.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,071.00 |
| Dec 31, 2025 | -3,697.00 |
| Sep 30, 2025 | -3,766.00 |
| Jun 30, 2025 | -3,730.00 |
| Mar 31, 2025 | -2,818.00 |
| Dec 31, 2024 | -2,802.00 |
| Sep 30, 2024 | -2,179.00 |
| Jun 30, 2024 | -90.00 |
| Mar 31, 2024 | 145.00 |
| Dec 31, 2023 | 185.00 |
| Sep 30, 2023 | -357.00 |
| Jun 30, 2023 | -1,673.00 |
| Mar 31, 2023 | -1,682.00 |
| Dec 31, 2022 | -1,372.00 |
| Sep 30, 2022 | -307.00 |